Clinical Trial

InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Prediction in Gastric Cancer

Study acronym: GRAMMY
Recruiting
View on ClinicalTrials.gov →
Summary
Multicentric, exploratory, non-pharmacologic, retrospective/prospective, translational study aiming to identify the molecular, cellular and psychological-sociological variables predictive of response to chemotherapy in gastric cancer patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-04-09.
Status change: Active, Not Recruiting → Recruiting 2024-11-19
Trial Details
NCT Number NCT04842916
Lead Sponsor Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Collaborators: ERA PERMED
Conditions Gastric Cancer
Enrollment 250 participants
Start Date 2020-09-22
Primary Completion 2027-05-22 (estimated)
Study Completion 2027-05-22 (estimated)
Updated on ClinicalTrials.gov 2024-11-21